109 related articles for article (PubMed ID: 8647779)
1. In-vitro effects of cefodizime on leucocyte functions and colony formation from granulocyte-monocyte progenitors.
Shin WS; Min CK; Kim YR; Yoo JH; Kang MW
J Antimicrob Chemother; 1996 Jan; 37(1):93-103. PubMed ID: 8647779
[TBL] [Abstract][Full Text] [Related]
2. Effects of cefotaxime and cefodizime on human granulocyte functions in vitro.
Labro MT; Babin-Chevaye C; Hakim J
J Antimicrob Chemother; 1986 Aug; 18(2):233-7. PubMed ID: 3019985
[TBL] [Abstract][Full Text] [Related]
3. In vitro and ex vivo enhancement of nonspecific phagocytosis by cefodizime.
Fietta A; Bersani C; Bertoletti R; Grassi FM; Grassi GG
Chemotherapy; 1988; 34(5):430-6. PubMed ID: 3053065
[TBL] [Abstract][Full Text] [Related]
4. Stimulatory effect of cefodizime on macrophage-mediated phagocytosis.
Oishi K; Matsumoto K; Yamamoto M; Morito T; Yoshida T
J Antibiot (Tokyo); 1989 Jun; 42(6):989-92. PubMed ID: 2737956
[TBL] [Abstract][Full Text] [Related]
5. Decrease in surface charge density of Klebsiella pneumoniae treated with cefodizime and enhancement of the phagocytic function of human polymorphonuclear leucocytes stimulated by the drug-treated bacteria.
Muratsugu M; Miyake Y; Ishida N; Hyodo A; Terayama K
Biol Pharm Bull; 1995 Sep; 18(9):1259-63. PubMed ID: 8845818
[TBL] [Abstract][Full Text] [Related]
6. Cefodizime (HR 221) potentiation of human neutrophil oxygen-independent bactericidal activity.
Labro MT; Amit N; Babin-Chevaye C; Hakim J
J Antimicrob Chemother; 1987 Mar; 19(3):331-41. PubMed ID: 3032885
[TBL] [Abstract][Full Text] [Related]
7. Immunological evaluation of cefodizime: a unique molecule among cephalosporins.
Labro MT
Infection; 1992; 20 Suppl 1():S45-7. PubMed ID: 1526677
[TBL] [Abstract][Full Text] [Related]
8. Antibiotics and production of granulocyte-macrophage colony-stimulating factor by human bronchial epithelial cells in vitro. A comparison of cefodizime and ceftriaxone.
Pacheco Y; Hosni R; Dagrosa EE; Gormand F; Guibert B; Chabannes B; Lagarde M; Perrin-Fayolle M
Arzneimittelforschung; 1994 Apr; 44(4):559-63. PubMed ID: 8011012
[TBL] [Abstract][Full Text] [Related]
9. Reduced anti-Pseudomonas aeruginosa activity of a cephalosporin, cefodizime, in rats whose neutrophils were selectively depleted by a monoclonal antibody.
Araki A; Sendo F
Microbiol Immunol; 1996; 40(5):333-8. PubMed ID: 8999285
[TBL] [Abstract][Full Text] [Related]
10. Influence of sub-minimum inhibitory concentrations of cefodizime on the phagocytosis, intracellular killing and oxidative bursts of human polymorphonuclear leukocytes.
Braga PC; Dal Sasso M; Mancini L; Sala MT
Chemotherapy; 1999; 45(3):166-74. PubMed ID: 10224338
[TBL] [Abstract][Full Text] [Related]
11. Effect of cefodizime on peritoneal mononuclear- and polymorphonuclear-cell chemotaxis.
Ustün H; Ersoy FF; Sezer T; Ozcan S; Bozcuk H; Yegin O; Balci M; Süleymanlar G; Yakupoglu G
Adv Perit Dial; 1998; 14():154-7. PubMed ID: 10649715
[TBL] [Abstract][Full Text] [Related]
12. The effects of some antibiotics on polymorphonuclear leukocyte functions of elderly patients in vitro before and after zinc supplementation.
Gürer US; Göçer P; Erçağ E; Erten N; Rayaman E; Gürbüz B; Uzer A; Karan A; Cevikbaş A
Int Immunopharmacol; 2006 May; 6(5):808-16. PubMed ID: 16546712
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cefodizime with various cephalosporins for their indirect effect on the human neutrophil oxidative burst in vitro.
Labro MT; el Benna J
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():49-57. PubMed ID: 2127416
[TBL] [Abstract][Full Text] [Related]
14. Effect of cefodizime on parameters of cell-mediated immunity in vitro.
Mallmann P; Brühl P; Dagrosa EE; Reeves A
Arzneimittelforschung; 1992 Apr; 42(4):567-70. PubMed ID: 1642684
[TBL] [Abstract][Full Text] [Related]
15. Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting.
Wenisch C; Bartunek A; Zedtwitz-Liebenstein K; Hiesmayr M; Parschalk B; Pernerstorfer T; Graninger W
Antimicrob Agents Chemother; 1997 Jul; 41(7):1584-8. PubMed ID: 9210690
[TBL] [Abstract][Full Text] [Related]
16. The effect of cefodizime on phagocyte function in non-patient volunteers and patients with chronic renal failure. In vitro and ex vivo studies.
McCafferty AC; McGregor E; Jones M; Henderson IS; Cree IA
Int J Clin Lab Res; 1996; 26(4):229-35. PubMed ID: 9007612
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation and immunomodulatory study of cefodizime].
Li G; Zhang Y; Ji M
Zhonghua Nei Ke Za Zhi; 1997 Nov; 36(11):759-63. PubMed ID: 10451950
[TBL] [Abstract][Full Text] [Related]
18. Influence of cefodizime on chemotaxis and the respiratory burst in neutrophils from diabetics.
Shaio MF; Chang FY
J Antimicrob Chemother; 1990 Jul; 26(1):55-9. PubMed ID: 2211447
[TBL] [Abstract][Full Text] [Related]
19. Influence of cefodizime on the reagibility of human leukocytes.
Limbert M; Müllner H; Shah PM
Infection; 1992; 20 Suppl 1():S48-50. PubMed ID: 1388140
[TBL] [Abstract][Full Text] [Related]
20. Sub-MIC concentrations of cefodizime interfere with various factors affecting bacterial virulence.
Braga PC; Sasso MD; Sala MT
J Antimicrob Chemother; 2000 Jan; 45(1):15-25. PubMed ID: 10629008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
